Patients younger than age 60 with Gleason 8-10 disease who had upfront surgery versus radiation therapy had a 63% lower risk of prostate cancer-specific mortality.
Mean 2.9 years gained after 23 years of follow-up among men with localized prostate cancer
According to researchers, 57.3% of men who underwent salvage robot-assisted radical prostatectomy were pad-free at 12 months.
Researchers question the generalizability of a major study showing no significant difference in cancer-specific and overall survival between surgery and observation for localized prostate cancer.
Gleason score at the margin can better stratify biochemical recurrence-free rates, according to study findings.
Study shows that the risk of recurrence after salvage radiotherapy is inversely related to the number of nodes resected at radical prostatectomy.
Perioperative aspirin use should not be considered an absolute contraindication to radical prostatectomy (RP).
The technology facilitates teaching of advanced surgical skills, delivery of care to underserved
Investigators have explored various strategies to prevent lymphoceles from forming.
Patient age 70 years and above is an independent risk factor for perioperative morbidity, according to data from a national cohort.
New technique uses silicone-based polymer inks to create prostate models with the tactile sensation, pliability, and texture of a real prostate.
Rates of erectile dysfunction and urinary incontinence at 1, 2, and 3 years after radical surgery are not higher among men who have multiple prostate biopsies while on active surveillance for prostate cancer.
Definitive comparative effectiveness data are lacking for salvage prostatectomy or salvage cryotherapy.
Physicians who treat patients with high-risk prostate cancer remain uncertain as to the optimal treatment approach, in part due to difficulty in interpreting study data.
Radical prostatectomy centers that closed from '10 to '14 more likely in areas with strong competition.
Study reveals that a quarter of men with low-volume intermediate-risk prostate cancer had adverse pathologic features found at radical prostatectomy.
Randomized trial found no significant difference in all-cause and cancer-specific survival between radical prostatectomy and observation for localized prostate cancer.
Over a 10-year period, radical prostatectomy use increased steadily while radiotherapy use declined
Younger patients who chose surgery vs radiation for initial treatment had a 48% survival advantage.
Urinary incontinence and diminished sexual function were common after a median follow-up of nearly 15 years, study finds.
Overall complication rates were similar between primary and salvage RARP groups, but there were some notable differences in prognosis.
Pathologic Gleason scores, positive surgical margin rates, and PSA doubling times differentiate earlier from later biochemical recurrence after radical surgery.
Patients with longer hospital stays and pre-discharge complications were at increased risk of readmission within 30 days of discharge.
Researchers found no evidence of worse cancer outcomes with nerve-sparing surgery.
Study compared PCa patients who underwent surgery or radiation treatment with a matched group of non-cancer controls.
No benefit of autologous urethral sling placement at robotic assisted radical prostatectomy on early return of continence at 6 months.
The pooled estimate for the overall attrition prevalence was 18%, with significant variation between studies.
Obesity predicts a wider range of complications in PCa patients who undergo laparoscopic or robot-assisted versus open radical prostatectomy.
Over a median follow-up of 70 months, 15% of men studied experienced biochemical recurrence.
Within each D'Amico risk category, African-American and Hispanic prostate cancer patients were less likely to receive definitive treatment than white patients.
Renal and Urology News Articles
- Pembrolizumab Shows Promise for BCG-Unresponsive Bladder Cancer
- Radical Cystectomy Superior to Trimodal Therapy for Muscle-Invasive Bladder Cancer
- Dialysis and Transplant Patients at Increased Risk for Cancer Death
- Tivozanib Offers Superior Outcomes in Refractory Metastatic Renal Cell Carcinoma
- Radiation, Chemotherapy Not Beneficial in Localized Upper Tract Urothelial Carcinoma
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)